l General Information |
Product Name | SBI-0206965 |
General description | SBI-0206965 is a highly selective autophagy kinase ULK1 inhibitor. |
Synonym | 2-[5-bromo-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxy-N-methylbenzamide |
Purity | ≥98.0%(HPLC) | CAS Number | 1884220-36-3 |
Formula | C21H21BrN4O5 | Molecular Weight | 489.32 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | ≥5mg/mL(warmed) |
Water | Insoluble |
l Biological Information |
Biochem/Physiol
Actions | SBI-0206965 is a highly selective autophagy kinase ULK1 inhibitor with IC50 of 108 nM, about 7-fold selectivity over ULK2. |
l Storage |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
